Literature DB >> 31161945

Influence of substrates and inhibitors on the structure of Klebsiella pneumoniae carbapenemase-2.

Ben A Shurina1, Richard C Page1.   

Abstract

Entities:  

Keywords:  Beta-lactamase; KPC-2; inhibitors

Year:  2019        PMID： 31161945      PMCID： PMC6920670          DOI： 10.1177/1535370219854322

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  83 in total

1.  In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study).

Authors:  A Walkty; M DeCorby; P R S Lagacé-Wiens; J A Karlowsky; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

2.  TEM-1 backbone dynamics-insights from combined molecular dynamics and nuclear magnetic resonance.

Authors:  Olivier Fisette; Sébastien Morin; Pierre-Yves Savard; Patrick Lagüe; Stéphane M Gagné
Journal:  Biophys J       Date:  2010-02-17       Impact factor: 4.033

3.  Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.

Authors:  K Bush; C Macalintal; B A Rasmussen; V J Lee; Y Yang
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  Ab initio QM/MM study of class A beta-lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70.

Authors:  Samy O Meroueh; Jed F Fisher; H Bernhard Schlegel; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2005-11-09       Impact factor: 15.419

5.  Structure-based approach for binding site identification on AmpC beta-lactamase.

Authors:  Rachel A Powers; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

6.  Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.

Authors:  Stephanie Petrella; Nathalie Ziental-Gelus; Claudine Mayer; Murielle Renard; Vincent Jarlier; Wladimir Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

7.  Beta-lactamase inhibitors. The inhibition of serine beta-lactamases by specific boronic acids.

Authors:  I E Crompton; B K Cuthbert; G Lowe; S G Waley
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

8.  Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226.

Authors:  Wei Ke; Christopher R Bethel; Krisztina M Papp-Wallace; Sundar Ram Reddy Pagadala; Micheal Nottingham; Daniel Fernandez; John D Buynak; Robert A Bonomo; Focco van den Akker
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

9.  Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.

Authors:  Wei Ke; Christopher R Bethel; Jodi M Thomson; Robert A Bonomo; Focco van den Akker
Journal:  Biochemistry       Date:  2007-04-19       Impact factor: 3.162

10.  Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance.

Authors:  Luke F Chen; Deverick J Anderson; David L Paterson
Journal:  Infect Drug Resist       Date:  2012-09-24       Impact factor: 4.003
View more
  2 in total

1.  Structural biology: Gaining atomic level insight into the biological function of macromolecules.

Authors:  Thomas B Thompson; Rhett A Kovall
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-13

2.  Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.

Authors:  Catherine L Tooke; Philip Hinchliffe; Robert A Bonomo; Christopher J Schofield; Adrian J Mulholland; James Spencer
Journal:  J Biol Chem       Date:  2020-12-03       Impact factor: 5.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.